SMTL ID : 8xkp.1

Crystal structure of human tyrosine-protein kinase Fes/Fps in complex with compound 17c

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: R.20, R.36, S.38, Q.39, K.41 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:S.38, A:Q.39 Salt bridges: A:R.20, A:R.36, A:K.41 SO4.2: 6 residues within 4Å: Chain A: R.235, R.259, Y.266, A.268, S.269, L.272 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Y.266, A:S.269, A:S.269 Salt bridges: A:K.156, A:R.235, A:R.259

1 x 01: 7-[[(1R,2S)-2-azanylcyclohexyl]amino]-5-[[3-[(2S,6R)-2,6-dimethylmorpholin-4-yl]phenyl]amino]-4-oxidanylidene-3H-pyrido[3,4-d]pyridazine-8-carbonitrile

01.3: 17 residues within 4Å: Chain A: I.120, R.122, A.141, K.143, E.160, V.173, M.189, E.190, L.191, V.192, Q.193, G.195, D.196, R.240, N.241, L.243, D.254 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.120, A:A.141, A:L.191, A:D.196, A:L.243 Hydrogen bonds: A:E.190, A:V.192, A:R.240, A:D.254, A:D.254 Water bridges: A:K.143

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Taniguchi, T. et al., Optimization of novel pyrido-pyridazinone derivatives as FER tyrosine kinase inhibitor to lead to the clinical candidate (highly potent compound) DS08701581. To Be Published

Release Date

2025-01-01

Peptides

Tyrosine-protein kinase Fes/Fps: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase Fes/Fps